These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 912965
1. Comparison of metrizamide with other myelographic agents. Bentson JR. Clin Orthop Relat Res; 1977; (127):111-9. PubMed ID: 912965 [Abstract] [Full Text] [Related]
2. Arachnoid response to contrast media: a comparison of iophendylate and metrizamide in experimental animals. Haughton VM, Ho KC. Radiology; 1982 Jun; 143(3):699-702. PubMed ID: 6805038 [Abstract] [Full Text] [Related]
3. Contrast agents for myelography: clinical and radiological evaluation of Amipaque and Pantopaque. Kieffer SA, Binet EF, Esquerra JV, Hantman RP, Gross CE. Radiology; 1978 Dec; 129(3):695-705. PubMed ID: 103130 [Abstract] [Full Text] [Related]
4. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography. Vézina JL, Fox AJ. J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380 [Abstract] [Full Text] [Related]
5. Clinical evaluation of metrizamide for neuroradiology in chilren. Swick HM, Sty JR, Haughton VM. Ann Neurol; 1978 May; 3(5):409-15. PubMed ID: 310277 [Abstract] [Full Text] [Related]
7. Metrizamide myelography for cervical spinal cord injuries. Leo JS, Bergeron RT, Kricheff II, Benjamin MV. Radiology; 1978 Dec; 129(3):707-11. PubMed ID: 725046 [Abstract] [Full Text] [Related]
8. Metrizamide: a review with emphasis on drug interactions. Hanus PM. Am J Hosp Pharm; 1980 Apr; 37(4):510-3. PubMed ID: 6103672 [Abstract] [Full Text] [Related]
10. Irreversible neurologic complications of metrizamide myelography. Meador K, Hamilton WJ, El Gammal TA, Demetropoulos KC, Nichols FT. Neurology; 1984 Jun; 34(6):817-21. PubMed ID: 6539448 [Abstract] [Full Text] [Related]
11. [Thoracic myelography with water-soluble contrast medium (metrizamide) (author's transl)]. Vogelsang H, Schmidt R, Grunwald F. Rofo; 1978 Mar; 128(3):342-5. PubMed ID: 147834 [Abstract] [Full Text] [Related]
12. [Use of non-ionogenic contrast media for myelography]. Sviridov NK, Popova ZP, Varfolomeeva VN. Zh Vopr Neirokhir Im N N Burdenko; 1984 Mar; (4):50-3. PubMed ID: 6388202 [No Abstract] [Full Text] [Related]
13. Comparative advantages of small- and large-dose metrizamide myelography. Solti-Bohman L, Bentson JR. AJR Am J Roentgenol; 1983 Oct; 141(4):825-8. PubMed ID: 6604437 [Abstract] [Full Text] [Related]
14. Development and evaluation of a new water-soluble iodinated myelographic contrast medium with markedly reduced convulsive effects. Hilal SK, Dauth GW, Hess KH, Gilman S. Radiology; 1978 Feb; 126(2):417-22. PubMed ID: 414304 [Abstract] [Full Text] [Related]
15. Comparison of myelographic agents for studying spinal dysraphism. Bentson JR. Clin Orthop Relat Res; 1978 Feb; (134):202-7. PubMed ID: 365412 [No Abstract] [Full Text] [Related]